50090-2573 : Oxcarbazepine 300 mg Oral Tablet


NDC50090-2573
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Oxcarbazepine
Dosage Form: Oral Tablet
Application #: ANDA077795
Rev. Date: 


NDC Package Codes:

  • 50090-2573-0: 33 BLISTER PACK IN 1 BOX (50090‑2573‑0) > 1 TABLET IN 1 BLISTER PACK

Active Ingredients:

  • Oxcarbazepine

Dosage Strength:

  • 300 mg

Pharmaceutical Classes:

  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]

Related Products:

Based on records with the same trade name.
  • 50090-3961 Oxcarbazepine 300 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-5003 Oxcarbazepine 300 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 0054-0097 Oxcarbazepine 150 mg Oral Tablet by Roxane Laboratories, Inc
  • 0054-0098 Oxcarbazepine 300 mg Oral Tablet by Roxane Laboratories, Inc
  • 0054-0099 Oxcarbazepine 600 mg Oral Tablet by Roxane Laboratories, Inc
  • 0054-0199 Oxcarbazepine 300 mg/5ml Oral Suspension by Roxane Laboratories, Inc
  • 0615-6593 Oxcarbazepine 150 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-6594 Oxcarbazepine 300 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-6595 Oxcarbazepine 600 mg Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-8153 Oxcarbazepine 150 mg Oral Tablet, Film Coated by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-8292 Oxcarbazepine 300 mg Oral Tablet, Film Coated by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-8447 Oxcarbazepine 150 mg Oral Tablet, Film Coated by Ncs Healthcare of Ky, LLC Dba Vangard Labs
  • 0615-8448 Oxcarbazepine 300 mg Oral Tablet, Film Coated by Ncs Healthcare of Ky, LLC Dba Vangard Labs
  • 0781-6270 Oxcarbazepine 60 mg/ml Oral Suspension by Sandoz Inc
  • 0904-7262 Oxcarbazepine 150 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 0904-7263 Oxcarbazepine 300 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 0904-7264 Oxcarbazepine 600 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 21695-862 Oxcarbazepine 150 mg Oral Tablet by Rebel Distributors Corp
  • 21695-863 Oxcarbazepine 300 mg Oral Tablet by Rebel Distributors Corp
  • 21695-864 Oxcarbazepine 600 mg Oral Tablet by Rebel Distributors Corp
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-2573 QR Code

< Prev: 50090-2572Next: 50090-2574 >

Related Discussions:

Oxcarbazepine drug information
Would like more information on this medication. Thank you ## Oxcarbazepine is considered a mood stabilizer, commonly use... 5 replies
oxetol 150 (Oxcarbazepine TAblets IP)'s USES..?
Plz tell me what is the meaning of all of this...multiple smaal gliotic foci are noted in the right medical occipital lo...
Concerned with Oxcarbazepine exhaustion
My wife has been taking Oxcarbazepine 150mg twice a day for a couple weeks now. Didn't notice at first but now she&#... 1 reply
Citalopram, Buspirone, Risperidone, or Oxcarbazepine?
Which psychotropic med requires drinking a plenty of water? ## I believe it is risperidone but I am cancelling my questi... 2 replies
propan with iron multivitamins together with trileptal oxcarbazepine
my husband is taking his maintenance medicine for his a.b malformation condition. he has been having a problem to sleep ... 2 replies
Oxcarbazepine and Suboxone
Why am i prescribed Oxcarbazepine 300 mg and Suboxone 2 mg? I don't get seizures or any convulsions, so what's t...
oxcarbazepine is safe in pragnency
My wife is taking oxcarbazepine (Tab Zenoxa 300) twice daily since last 9 month. She wish to have pregnancy. Will there ...
oxcarbazepine side effects
long term effects of oxcarbazepine...
alcohol and oxcarbazepine 300
Dear Sir /Madam Greetings, I am having Tab Zenoxa 300 thrice a day and Tab Encrote Chorono 500 twice a day since 2012 Ap...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.